BioBoard

Australia
•  First iPS Cell Line Puts Australia in the Lead of Stem Cell Research
•  New Treatment Hope for Prostate Cancer

China
•  AIDS Is China's Top Killer Among Infectious Diseases
•  Anti-bird Flu Drug for Human Clinical Trial Approved by China
•  China Plans 120 Billion Dollar Health Reform By 2011
•  13 000 Fowl Culled in China After Bird flu
•  China-Russia Joint Research Center
•  Pig's Adult Stem Cells Produce Better Skins
•  More Health Scares Amid Slowdown, Warns China

India
•  Indian Experts Find Bacteria to Beat Global Heat
•  Two Indian Firms to Set Up Pre-clinical Trial Units in Malaysia

Japan
•  Breakthrough in Universal Flu Vaccine Development

Singapore
•  Taiwan Pork Banned by AVA
•  Stem-Cell Treatment For Joint Pain Gives New Hope
•  Next Generation Healthcare Information System
•  Top US University Sets Up Research Centre in Singapore
•  Increase in Life-saving Umbilical Cord Donations
•  Singapore and China Scientists Report Breakthrough Research in Psoriasis

SOUTH KOREA
•  Harmful Bacteria in French Baby Formula
•  World's First Cloned Wolves to Test Reproductive Fitness

Taiwan
•  Genetic Testing on the Rise
•  Chinese Herbal Medicines Contain Western Drug Ingredients

Vietnam
•  Bird Flu Strikes in Five Provinces in Vietnam
•  Opening of Vietnam's First Stem Cell Bank, "MekoStem"
•  Hanoi Suffers Worst Measles Outbreak in Decade

OTHER REGIONS
Europe
•  Social Networking = Disease?
•  Cancer Morbidity 'to Double in 40 Years'

North America
•  Scientists Close in on 'Universal' Vaccine for Flu
•  Hong Kong and US Scientists Develop New Bird Flu Vaccine

Feature
•  Do Asian Breast Cancer Patients Have Poorer Survival Than Their Western Counterparts? A Comparison Between Singapore and Stockholm.
•  Large Family With Both Parents Affected by Distinct BRCA1 Mutations: Implications For Genetic Testing

Commentary and Analysis
•  The Elimination of Hospital Acquired Infections: A Realistic Goal?

Industry Watch
•  Arana Announces Issuance of Key European Patent for Evibodies
•  Living Cell Technologies Reports Interim Results Showing Sustained Benefit with DIABECELL® Implants for Insulin Dependent Diabetes
•  Topical Microbicide Field Receives Boost with Human Efficacy Result
•  WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year
•  Syngenta Enters into Research Collaboration with Anhui Academy, China
•  Bayer Schering Pharma to Invest 100 Million Euro in China to Build a Global R&D Center
•  Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
•  World's First Robotic Radiosurgery System Introduced at Apollo Hospitals
•  Fortis Ties up with International Oncology
•  Apotex and Intas Biopharma Partner to Develop Biosimilars
•  Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
•  Schering-Plough Opens First R&D Centre in Singapore
•  Hyflux Still Expanding
•  GSK to Commit $1.3 Million to Singapore Institute's Vaccine Development Projects
•  Invida to Market Breakthrough Anti-nausea Patch in Asia Pacific
•  NUS Partners International Rice Research Institute to Address Global Food Security Challenge
•  Singapore Research Organizations Team up to Advance Drug Discovery Using Brain Tumor Stem Cells

Research and Findings
•  Bioremediation to Keep Arazine from Waterways
•  Fifth Brain Disorder Gene Located
•  Moving towards Emerging Field of Mechanobiology
•  Singapore and Israel Join Forces in Research and Innovation

Product News
•  A Made-in-Singapore Invention Keeps our Hearts in Check

People Watch
•  Biota Appoints New Chairman
•  Harvard Professor to Lead CSIRO's Maths Research
•  Fluorotechnics appoints James Walker as CEO and Duncan Veal as Chief Technology Officer
•  pSivida Corp Appoints New President and Chief Executive Officer
•  SCBA Award Gives Recognition to Prominent Chinese Bioscientists Around the World

Conference Calendar